DOI:
10.1055/s-00000072
Seminars in Reproductive Medicine
LinksClose Window
References
U.S. Food and Drug Administration.
Quantitative assessment of the prevalence of unsuspected uterine sarcoma in women undergoing treatment of uterine fibroids. summary and key findings.
FDA Safety Communications 2014;
213: e1-e6
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.